SPRYCEL 100 MG TABLET

dasatinib
$591.1810per EA
High Outlier

Strength

100 mg/1

NDC

00003085222

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

DASATINIB

Approval Type

New Drug (NDA)

FDA Application

NDA021986

On Market Since

5/30/2008

Pharmacological Classes

Cytochrome P450 3A4 Inhibitors
Kinase Inhibitor
Protein Kinase Inhibitors

Price History

1W

0.0%

1M

+0.0%

3M

+0.1%

6M

+0.1%

1Y

+0.1%

3Y

+9.2%

5Y

+21.4%

All

+103.9%